The best conference for health and life sciences students in europe!
The science behind medical knowledge - learn about current research on diverse fields of study and its implications for the future of medicine.
A Nobel laureate, a Lasker winner and top notch researchers will come to Lisbon to share their knowledge and experience.
Enjoy the opportunity to meet and mingle with other Health and Life Sciences students and professionals.
At the iMed Conference® we invite internationally renowned scientists and doctors to share how they have looked further.
THE NEW ERA OF AGING
Dr. Aubrey de Grey is a biomedical gerontologist based in Cambridge, United Kingdom, and Mountain View, California, United States of America, and is currently the Chief Science Officer of SENS Research Foundation. He is also Editor-in-Chief of Rejuvenation Research, the world’s most impacting peer-reviewed journal focused on intervention in ageing. He received his BA in Computer Science and his Ph.D. in Biology from the University of Cambridge. His research interests encompass the characterization of all the accumulative, and eventually pathogenic, molecular and cellular side effects of metabolism that constitute mammalian ageing, and the designing of interventions to repair and/or obviate this damage. Dr. de Grey is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organisations.
GET SMARTER THAN A MOSQUITO
Dutch Malaria Foundation
“If you think you're too small to have an impact, try going to sleep with a mosquito in the room”. This is the quote that Dr.Bart Knols uses to introduce his research work. In the XXI century nearly half of the world's population is at risk for contracting malaria and 438 000 deaths are estimated to be attributable to the disease. Hence, Dr.Knols has devoted his entire career to the study of mosquitoes and the diseases they transmit, leading him to win the Ig Nobel Prize and the Eijkman medal.
3D SKULL – NEW ERA OF SKULL TRANSPLANTATION
Professor Bon Verweij is a Neurosurgeon at the University Medical Center in Utrecht, Netherlands. Specialized in Vascular Neurosurgery he is also an active researcher with multiple articles published on the subjects of Neurotraumatology, and Vascular Brain Diseases. Over the last years he has been arguing for the application of technologies such as Virtual Reality and 3D printing to optimize surgical procedures and make them safer. It was 2014, and in a 23-hour surgery, Dr.Verweij and his colleague Dr. Marvick Murrain made history by sucessfully conducting the first skull transplantation surgery using 3D printing.
STEM CELLS TREATMENT FOR OSTEOGENESIS IMPERFECTA IN UTERO
Professor and Director for the Doctoral Program in Regenerative Medicine at Karolinska Insitutet, Cecilia Göthersström runs the National Umbilical Cord Blood Bank in Sweden and is the main researcher at the Centre for Haematology and Regenerative Medicine. The use of stem cells in the clinical practice is one of the main goals of her research, particularly the potential for the cure of genetic diseases such as osteogenesis imperfecta. Her participation in the iMed Conference 8.0 will reveal the first data from the clinical phase of this study.
INFLAMMATION AND CANCER AT THE CLINIC
Frances Balkwill is Professor of Cancer Biology at Barts Cancer Institute, Queen Mary University of London, where she leads the Centre for Cancer and Inflammation and the Cytokine and Cancer Group. Dr. Balkwill is also Director of the Centre of the Cell, a biomedical sciences centre for children, and Fellow of the Academy of Medical Sciences. Her research is focused on the links between cancer and inflammation – particularly the role inflammatory cytokines play in cancer promotion – and is especially concerned with the translation of this knowledge into new biological treatments for cancer.
NONINVASIVE PRENATAL TESTING AND PRESYMPTOMATIC IDENTIFICATION OF CANCER IN PREGNANT WOMEN
Professor Frédéric Amant is a Belgian Gynaecologic Oncologist responsible for the scientific section of Gynaecological Oncology at the Catholic University of Louvain, Belgium. He leads the International Network on Cancer, Infertility and Pregnancy of the European Society of Gynaecological Oncology, is a member of the Endometrium Tumour Site Committee of the European Organization for Research and Treatment of Cancer and of the European Network Individualized Treatment in Endometrial Cancer. He is also a collaborator in numerous scientific journals such as the European Journal of Obstetrics and Gynaecology and Reproductive Biology and has authored/co-authored more than 100 scientific articles. In his participation a new non-invasive prenatal diagnosis application will be introduced to the audience.
Doctors Without Borders
In more economically developed countries Health Care is guaranteed, but are we aware of the reality for the rest of the world? Do you know what MSF does and in which situations the organisation intervenes? As a future doctor, would you be able to act with only sparse resources?
Doctor Gilles Van Cutsem, who is Medical Coordinator for MSF in South Africa and Honorary Research Associate at the Centre for Infectious Disease Epidemiology and Research of the University of Cape Town, is going to answer all these questions and more whilst relating tragic cases that happened in the field.
REFLECTIONS OF A WAR SURGEON
Dr. Gino Strada graduated in Medicine and Emergency Surgery from the University of Milan, subsequently becoming a heart and lung transplant surgeon. In 1988 Dr. Strada was heading for conflict zones and in 1994 he was co-fouding the NGO EMERGENCY. This organisation coordinates more than 60 hospitals, clinics and first aid posts and by 2015, EMERGENCY had operated in 15 countries – providing medical and surgical assistance to over 6 million people. Dr. Gino Strada's vision of high quality gratis medicine in war zones was a paradigm shift and has since proved itself a revolutionary idea – the Salam Centre for Cardiac Surgery being the best example. Dr. Strada has fought many battles against war, even speaking out against his own government when needed be, and has had a major contribution in banning the production of land mines in Italy. In 2015 he won The Right Livelihood Award, the alternative Nobel Prize for Peace.
EXPERIMENTAL DEMENTIA RESEARCH
Professor Gunnar Keppler Gouras is professor of Neuroscience and group leader of the experimental Dementia Research Unit in the department of Experimental Medical Science in the Faculty of Medicine, at Lund University. The focus of his team is to elucidate the mechanisms of early synapse dysfunction in Alzheimer’s disease (AD) and related neurodegenerative disorders. His group was the first to report on β-amyloid (Aβ) accumulation in endosomes and synapses in Alzheimer’s disease, among other physiological mechanisms. Past honors include Merck Young Investigator Award in Alzheimer’s disease from the American Academy of Neurology (2001), and Temple (2003) and Zenith (2007) awards from the Alzheimer’s Association.
Professor Janet Eyre is Professor of Paediatric Neuroscience at Newcastle University in the UK. She is an internationally recognised expert in brain plasticity following brain injury, investigating the development and the factors governing plasticity of the corticospinal system throughout life and its implications in rehabilitation. She currently leads a research program studying the clinical application of video games to online physiotherapy, thus enabling home-based-delivery of therapy with expert remote monitoring and management by therapists. She has received several awards for her work, namely the Medical Futures Best Innovation to Improve Patient Care—Cardiovascular Innovation Award 2011 and the Medical Futures National Health Service Innovation of the Year Award 2012.
Could genetics be the basis for complex mental disorders such as schizophrenia or depression? Through his extensive research on rodent models and human genomics, Professor Jonathan Flint has contributed for a better understanding of Psychiatry. Currently at the University of California Los Angeles’ Department of Psychiatry, Professor Flint has performed most of his research work at the Wellcome Trust Centre for Human Genetics, in Oxford. With numerous articles published, and several communications, both at scientific and Economics events, his results have brought a novel perspective on the genetic basis of behavioural and mental disorders, as well as a new target for further treatments and management strategies in Modern Psychiatry.
Researchers have managed to understand how our mind can modulate our immune system. But can our immune system determine our mental health? José Oliveira, MD, PhD, is currently studying this phenomenon through his research on Psychoneuroimmunology. He graduated in Medicine from the University of Coimbra, Portugal, after what he started his residency in Psychiatry in Centro Hospitalar Psiquiátrico de Lisboa. He completed his PhD at the Translational Psychiatry Laboratory of Mondor Institut for Biomedical Research in Paris, with particular interest in the immunogenetics of psychiatric disorders and their potential interactions with environmental risk factors such as perinatal infection and childhood trauma.
VIRUS AGAINST CANCER
Kevin Harrington is Professor of Biological Cancer Therapies and Joint Head of the Division of Radiotherapy and Imaging, at The Institute of Cancer Research. He is also an honorary consultant oncologist at The Royal Marsden and a Fellow of the Royal College of Physicians and of the Royal College of Radiologists. Professor Harrington is a specialist in melanoma and head and neck cancer. He leads the Targeted Therapy Team in the Division of Cancer Biology which is focused on developing new strategies to target cancer cells selectively, involving biologically targeted agents in combination with treatments such as radiotherapy and chemotherapy.
CLINICAL MIND COMPETITION
Dr. Lisa Sanders is an American board-certified internist at Yale-New Haven Hospital. Dr.Sanders first majored in English and later graduated in Medicine at Yale School of Medicine, where she is currently a teacher. Lisa Sanders took a job with ABC early on and after that worked for CBS News, winning an Emmy Award for Outstanding Coverage of a Breaking News Story, and is currently the author of the popular New York Times Magazine's Diagnosis column – the inspirational idea behind the TV series House, MD. Furthermore, Dr. Sanders is also the author of the featured title Think Like a Doctor and the best-selling book "Every Patient Tells a Story:Medical Mysteries and the Art of Diagnosis".
SCIENTIFIC PUBLISHING – WHAT IS NEXT?
Doctor Maria Leptin received her PhD for her work on B cell activation carried out at the Basel Institute for Immunology. She joined the laboratory of Michael Wilcox at the Medical Research Council’s Laboratory of Molecular Biology (LMB) in Cambridge, where she studied the development in Drosophila. In 1994 Dr.Leptin became Professor at the Institute of Genetics University of Cologne and in 2010 Director of EMBO. Still in 2010, she established a research group in Heidelberg at the European Molecular Biology Laboratory (EMBL) that studies the development of the cell shape in the respiratory system of Drosophila. Dr. Leptin also serves on the editorial boards of the Developmental Cell and the Developmental Biology journals and on advisory boards of several academic institutions.
THE INNOVATIVE SURGEON
Great Ormond Street Hospital
Would you do everything to save your paediatric patient’s life? Even if it was an all-new procedure? Professor Martin Elliot took his duty by heart and never gave up on fighting for his patient. The result? A grateful family, jubilant over it's member's survival, and original, trailblazing information on tracheal tissue engineering and stem-cell supported transplant.
Dr. Martin Elliot is Professor of Paediatric Cardiothoracic Surgery, has over 280 peer reviewed publications and has delivered more than 320 lectures – in this edition of the iMed Conference he will certainly inspire us with his invaluable knowledge.
GENES AND TUMORIGENESIS
Having been awarded with the Nobel Prize in Medicine, in 1989, Professor Michael Bishop was pioneer in research involving oncogenic retroviruses, as he discovered the first human oncogene – c-Src –, and his findings led to the understanding of cellular alterations in oncogenesis. With his book How to Win the Nobel Prize: An Unexpected Life in Science, Professor Bishop will now inspire new generations of scientists in the pursuit of knowledge.
THE NEW ERA OF CANCER
Michael Lisanti is Professor of Cancer Biology and Breast Oncology, Director of the Manchester Breakthrough Breast Cancer Research Unit, and the new founding Director of the Manchester Centre for Cellular Metabolism, at the University of Manchester. Professor Lisanti was the first to propose the Reverse Warburg Effect. This new model for cancer metabolism will enable the development of novel diagnostic and therapeutic strategies towards a personalised cancer approach. Recently he has investigated the effects of antibiotics on the mitochondria of cancer stem cells, finding new pathways for the eradication of cancer cells.
THE DEVELOPING BRAIN
Professor Petra Hüppi is a clinician in Paediatrics. Since 1998, she has been leading the Child Development Unit and the Division of Development and Growth at the Department of Paediatrics of Geneva University Hospitals, Switzerland. She is a full-time Professor at the University of Geneva and conducts international research activities, whilst holding a visiting scientist position at Harvard Medical School, USA. Her research projects are focused on early human brain development having significantly contributed to the understanding of specific brain deficits found in prematurely born children. Currently, Professor Hüppi serves as a Board of Trustee Member of the International Society for Magnetic Resonance in Medicine and is an Elected Member of the National Research Council in both Switzerland and France. She is also the founder of the European Association for Developmental Care.
THE LIVER TRANSPLANT
British surgeon Professor Roy Calne was a pioneer in the field of transplantation and was also involved in the development of immunosuppressants to extend survival of organ recipients. Throughout his career, he was awarded several prizes, including the Lister Medal, from the Royal College of Surgeons of England, and the Lasker-DeBakey Clinical Medical Research Award. His scientific breakthroughs are certain to inspire the audience at this year's edition of the iMed Conference.
Oxford Martin School Institute of Nanoscience for Medicine.
From the moment that Medicine started looking at diseases as systemic pathologies arose the need to create targeted therapeutics. The goals? To minimize the adverse effects, to tackle the growing problem of bacterial resistance to antibiotics and to fight the disease acting directly on the cause. Sonia Trigueros’ research focuses on designing a novel nanodrug delivery system to target dividing cells, specifically cancer cells.
It is safe to say that nanotechnologies have reduced drug delivery systems to molecular and atomic level has much as they have raised curative chances to astronomic units.
Currently based in Exeter University, Professor Thorsten Barnhofer is one of the main contributors to the development of mindfulness-based techniques for patients with chronic mental diseases such as major depression. He worked alongside Professor Mark Williams at Oxford, as well as other notable references in this area, and further explored the neurobiological mechanisms underlying the treatment for chronic mental diseases, at Freie Universität Berlin. After having presented his perspective to researchers and prominent personalities such as His Holiness the 14th Dalai Lama, he will share, in this 8th edition of the iMed Conference, his most recent results and prospects for the near future.
Centro Cultural de Belém
Praça do Império, 1449-003 Lisboa
13th - 16th
Enjoy the opportunity to meet and mingle with other Health and Life Sciences students and professionals.
More info about our schedule will be available soon.
It is thanks to our amazing partners that we are able to host this conference!
Interested in becoming a sponsor? Get in touch!